Regulation of bone remodeling by the central and peripheral nervous system

2008/03/24 by Florent Elefteriou · 26 citations
Neuroscience · Medicine · #Neuropeptides and Animal Physiology #Regulation of Appetite and Obesity #Biochemical effects in animals

paper · doi:10.1016/j.abb.2008.03.016

Cited by

• Pregnancy and lactation, a challenge for the skeleton
• Transient muscle paralysis disrupts bone homeostasis by rapid degradation of bone morphology. [europepmc]
• Bone mass in Rett syndrome: association with clinical parameters and MECP2 mutations. [europepmc]
• Marrow fat metabolism is linked to the systemic energy metabolism. [europepmc]
• Bone mechanotransduction may require augmentation in order to strengthen the senescent skeleton. [europepmc]
• New roles of carboxypeptidase E in endocrine and neural function and cancer. [europepmc]
• Socioeconomic status over the life-course and adult bone mineral density: the Midlife in the U.S. Study. [europepmc]
• The role of osteocalcin in human glucose metabolism: marker or mediator? [europepmc]
• Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases. [europepmc]
• Inner Ear Vestibular Signals Regulate Bone Remodeling via the Sympathetic Nervous System. [europepmc]
• Biomechanical aspects of the muscle-bone interaction. [europepmc]
• Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. [europepmc]
• In vivo and In vitro Identification of Endocannabinoid Signaling in Periodontal Tissues and Their Potential Role in Local Pathophysiology. [europepmc]
• Exosomes: novel regulators of bone remodelling and potential therapeutic agents for orthodontics. [europepmc]
• Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism. [europepmc]
• Muscle-Bone Crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to Treat Musculoskeletal Pathologies. [europepmc]
• Impact of the Autonomic Nervous System on the Skeleton. [europepmc]
• Etiology and Measurement of Peri-Implant Crestal Bone Loss (CBL). [europepmc]
• Bone loss caused by dopaminergic degeneration and levodopa treatment in Parkinson's disease model mice. [europepmc]
• Osteopontin in Bone Metabolism and Bone Diseases. [europepmc]
• In silico experiments of bone remodeling explore metabolic diseases and their drug treatment. [europepmc]
• Pregnancy and lactation, a challenge for the skeleton. [europepmc]
• Dopamine suppresses osteoclast differentiation via cAMP/PKA/CREB pathway. [europepmc]
• Effects of Neurological Disorders on Bone Health. [europepmc]
• Bone-to-Brain: A Round Trip in the Adaptation to Mechanical Stimuli. [europepmc]
• Neuro-bone tissue engineering: emerging mechanisms, potential strategies, and current challenges. [europepmc]